HYPD on Nasdaq
HYPERION DEFI, INC.
American finance services company that raised $50 million in 2025 (SEC Form D). Summary from the record
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Netcapital Inc., NFT Ltd or Decentral Life, Inc., or pick any stock.
- TickerHYPD on Nasdaq1
- IndustryFinance Services1
- HeadquartersDallas, Texas1
- Incorporated inDE2
- Business address3090 Nowitzki Way, Suite 300, Dallas, Tx 752192
- Filer categoryNon-accelerated filer, Smaller reporting company2
- Legal formCorporation
See how the biggest companies compare on our leaderboards
We were organized as a corporation under the laws of the State of Florida on March 12, 2014 under the name “PGP Holdings V, Inc.” On May 5, 2014, we changed our name to Eyenovia, Inc. On October 6, 2014, we reincorporated in the State of Delaware by merging into Eyenovia, Inc., a Delaware corporation. On July 1, 2025, we changed our name to Hyperion DeFi, Inc. Our principal executive office is located at 23461 S. Pointe Drive, Suite 390, Laguna Hills, CA 92653, and our telephone number is (833) 393-6684. We maintain a website at www.hyperiondefi.com, to which we regularly post copies of our press releases as well as additional information about us. The information contained on, or that can be accessed through, our website is not a part of this report. We have included our website address in this report solely as an inactive textual reference.3 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
62.7%Gross margin4
-5743.5%Operating margin4
-5570.6%Net margin4
1318.8%Revenue growth, 20254
-110.4%Return on equity4
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Digital Assets brought in 98% of the revenue HYPERION DEFI, INC. broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Digital Assets | $798.7K | |
| Ophthalmic Technology | $57.3K | $14.7K |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue2¢$303.3K
- Research and development10¢$1.9M
- Selling, general and admin88¢$17.2M
- Income tax0¢$30.9K
Out of $813.5K in revenue.4 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenue | $813.5K | $57.3K |
| Cost of revenue | -$303.3K | -$3.9M |
| Gross Profit (Loss) | $510.2K | -$3.9M |
| Research and development | $1.9M | $14.5M |
| Selling, general and administrative | $17.2M | $14.3M |
| Realized gain - digital assets | -$8.3M | |
| Unrealized loss - digital assets | $9.0M | |
| Impairment loss - digital assets | $27.2M | |
| Impairment loss - other assets | $11.2M | |
| Gain on covered call option | -$157.6K | |
| Provision for credit losses | $405.3K | |
| Reacquisition of license rights | $4.9M | |
| Net Operating Expenses | $47.2M | $44.9M |
| Loss From Operations | -$46.7M | -$48.7M |
| Other income (expense), net | $389.7K | -$90.6K |
| Gain on extinguishment of liabilities | $2.3M | |
| Change in fair value of equity consideration payable | $1.2M | |
| Interest expense | -$1.6M | -$2.5M |
| Interest income | $240.0K | $254.0K |
| Total Other Income (Expense), Net | $1.4M | -$1.1M |
| Net Loss | -$45.3M | -$49.8M |
| Dividend to preferred stockholders | -$1.7M | |
| Net Loss Attributable to Common Stockholders | -$47.0M | -$49.8M |
| Net Loss per Share - Basic (in dollars per share) | -$9.40 | -$59.81 |
| Net Loss per Share - Diluted (in dollars per share) | -$9.40 | -$59.81 |
| Shares Outstanding - Basic (in shares) | 5.0M shares | 833.0K shares |
| Shares Outstanding - Diluted (in shares) | 5.0M shares | 833.0K shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 5 fiscal years (annual) or 5 quarters (quarterly), latest first.4
| Period ending | 2025-12-31 | 2025-08-31 | 2024-12-31 | 2024-05-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $6.4M | $2.1M | |||
| Prepaid expenses and other current assets | $802.3K | $645.7K | |||
| Total Current Assets | $7.2M | $2.8M | |||
| Digital assets | $16.3M | ||||
| Digital assets receivable, net | $6.9M | ||||
| Digital intangible assets | $20.6M | ||||
| Operating lease right-of-use asset | $416.0K | $718.4K | |||
| Other assets | $230.4K | $182.2K | |||
| Total Assets | $51.8M | $3.7M | |||
| Accounts payable | $317.9K | $2.0M | |||
| Accrued former licensor obligations | $2.2M | ||||
| Accrued expenses and other current liabilities | $1.9M | $1.3M | |||
| Operating lease liabilities - current portion | $512.0K | $575.2K | |||
| Notes payable - current portion, net of debt discount of $0 and $527,870 as of December 31, 2025 and December 31, 2024, respectively | $5.2M | ||||
| Convertible notes payable - net of debt discount of $0 and $263,930 as of December 31, 2025 and December 31, 2024, respectively | $4.7M | ||||
| Total Current Liabilities | $2.7M | $16.0M | |||
| Notes payable - non-current portion, net of debt discount of $543,230 and $0 as of December 31, 2025 and December 31, 2024, respectively | $7.8M | ||||
| Operating lease liabilities, non-current portion | $206.6K | $717.5K | |||
| Total Liabilities | $10.7M | $16.8M | |||
| Preferred stock, $0.0001 par value, 60,000,000 shares authorized; Series A Non-Voting Convertible Preferred Stock, 5,435,898 shares designated, and 5,435,897 and 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively, with a liquidation preference of $50,795,000 as of December 31, 2025 | $544 | ||||
| Common stock, $0.0001 par value, 600,000,000 shares authorized; 8,762,329 shares issued and 8,680,005 shares outstanding as of December 31, 2025 and 1,506,369 shares issued and outstanding as of December 31, 2024 | $876 | $151 | |||
| Additional paid-in capital | $281.9M | $182.2M | |||
| Treasury stock, at cost, 82,324 shares as of December 31, 2025 | -$253.6K | ||||
| Accumulated deficit | -$240.6M | -$195.3M | |||
| Total Stockholders' Equity (Deficit) | $41.1M | -$13.1M | $9.0M | ||
| Total Liabilities and Stockholders' Equity (Deficit) | $51.8M | $3.7M | |||
| Notes payable - current portion, net of debt discount | $0 | $527.9K | |||
| Convertible notes payable - net of debt discount | $0 | $263.9K | |||
| Notes payable - non-current portion, net of debt discount | $543.2K | $0 | |||
| Preferred stock, par value | $0.00 | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 60.0M shares | 60.0M shares | 60.0M shares | ||
| Preferred stock, shares issued | 5.4M shares | 0 shares | |||
| Preferred stock, shares outstanding | 5.4M shares | 0 shares | |||
| Preferred stock liquidation preference | $50.8M | ||||
| Common stock, par value | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 600.0M shares | 600.0M shares | 600.0M shares | 90.0M shares | |
| Common stock, shares issued | 8.8M shares | 1.5M shares | |||
| Common stock, shares outstanding | 8.7M shares | 1.5M shares | |||
| Treasury stock, at cost, shares | 82.3K shares |
| Period ending | 2025-12-31 | 2025-08-31 | 2024-12-31 | 2024-05-31 | 2023-12-31 |
|---|---|---|---|---|---|
| Cash and cash equivalents | $6.4M | $2.1M | |||
| Prepaid expenses and other current assets | $802.3K | $645.7K | |||
| Total Current Assets | $7.2M | $2.8M | |||
| Digital assets | $16.3M | ||||
| Digital assets receivable, net | $6.9M | ||||
| Digital intangible assets | $20.6M | ||||
| Operating lease right-of-use asset | $416.0K | $718.4K | |||
| Other assets | $230.4K | $182.2K | |||
| Total Assets | $51.8M | $3.7M | |||
| Accounts payable | $317.9K | $2.0M | |||
| Accrued former licensor obligations | $2.2M | ||||
| Accrued expenses and other current liabilities | $1.9M | $1.3M | |||
| Operating lease liabilities - current portion | $512.0K | $575.2K | |||
| Notes payable - current portion, net of debt discount of $0 and $527,870 as of December 31, 2025 and December 31, 2024, respectively | $5.2M | ||||
| Convertible notes payable - net of debt discount of $0 and $263,930 as of December 31, 2025 and December 31, 2024, respectively | $4.7M | ||||
| Total Current Liabilities | $2.7M | $16.0M | |||
| Notes payable - non-current portion, net of debt discount of $543,230 and $0 as of December 31, 2025 and December 31, 2024, respectively | $7.8M | ||||
| Operating lease liabilities, non-current portion | $206.6K | $717.5K | |||
| Total Liabilities | $10.7M | $16.8M | |||
| Preferred stock, $0.0001 par value, 60,000,000 shares authorized; Series A Non-Voting Convertible Preferred Stock, 5,435,898 shares designated, and 5,435,897 and 0 shares issued and outstanding as of December 31, 2025 and December 31, 2024, respectively, with a liquidation preference of $50,795,000 as of December 31, 2025 | $544 | ||||
| Common stock, $0.0001 par value, 600,000,000 shares authorized; 8,762,329 shares issued and 8,680,005 shares outstanding as of December 31, 2025 and 1,506,369 shares issued and outstanding as of December 31, 2024 | $876 | $151 | |||
| Additional paid-in capital | $281.9M | $182.2M | |||
| Treasury stock, at cost, 82,324 shares as of December 31, 2025 | -$253.6K | ||||
| Accumulated deficit | -$240.6M | -$195.3M | |||
| Total Stockholders' Equity (Deficit) | $41.1M | -$13.1M | $9.0M | ||
| Total Liabilities and Stockholders' Equity (Deficit) | $51.8M | $3.7M | |||
| Notes payable - current portion, net of debt discount | $0 | $527.9K | |||
| Convertible notes payable - net of debt discount | $0 | $263.9K | |||
| Notes payable - non-current portion, net of debt discount | $543.2K | $0 | |||
| Preferred stock, par value | $0.00 | $0.00 | $0.00 | ||
| Preferred stock, shares authorized | 60.0M shares | 60.0M shares | 60.0M shares | ||
| Preferred stock, shares issued | 5.4M shares | 0 shares | |||
| Preferred stock, shares outstanding | 5.4M shares | 0 shares | |||
| Preferred stock liquidation preference | $50.8M | ||||
| Common stock, par value | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common stock, shares authorized | 600.0M shares | 600.0M shares | 600.0M shares | 90.0M shares | |
| Common stock, shares issued | 8.8M shares | 1.5M shares | |||
| Common stock, shares outstanding | 8.7M shares | 1.5M shares | |||
| Treasury stock, at cost, shares | 82.3K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$45.3M | -$49.8M |
| Stock-based compensation | $6.4M | $1.7M |
| Change in fair value of equity consideration payable | -$1.2M | |
| Depreciation of property and equipment | $1.1M | |
| Amortization of debt discount | $656.0K | $759.0K |
| Asset impairments | $11.2M | |
| Write-down of inventories to net realizable value | $3.1M | |
| Reacquisition of license rights | $2.9M | |
| Non-cash lease expense | $302.4K | $528.4K |
| Gain on extinguishment of liabilities | -$2.3M | |
| Non-cash realized gain - digital assets | -$8.3M | |
| Unrealized loss - digital assets | $9.0M | |
| Impairment loss - digital assets | $27.2M | |
| Staking income | -$554.1K | |
| Non-cash commission paid to co-validators | $26.2K | |
| Provision for credit losses | $405.3K | |
| Unamortized non-refundable upfront fee on digital asset receivable | $307.3K | |
| Paid-in-kind interest expense | $380.0K | |
| Prepaid expenses and other current assets | -$156.6K | $554.0K |
| License fee and expense reimbursement receivables | $99.0K | |
| Deferred clinical supply costs | $868.3K | |
| Security and equipment deposits | -$48.2K | $1.5K |
| Accounts payable | -$1.6M | $446.6K |
| Accrued compensation | -$1.5M | |
| Accrued expenses and other current liabilities | -$497.7K | -$293.6K |
| Lease liabilities | -$574.1K | -$501.2K |
| Net Cash and Cash Equivalents Used In Operating Activities | -$14.8M | -$30.1M |
| Purchase of property and equipment | -$161.5K | |
| Purchase of productive digital assets | -$72.0M | |
| Net Cash and Cash Equivalents Used In Investing Activities | -$72.0M | -$161.5K |
| Proceeds from sale of common stock and warrants in direct offering | $19.4M | |
| Proceeds from sale of preferred stock and warrants in private placement | $50.0M | -$2.4M |
| Payment of private placement issuance costs | -$634.2K | |
| Proceeds from sale of common stock in At the Market offering | $40.6M | $6.2M |
| Payment of issuance costs for At the Market offering | -$1.3M | -$187.0K |
| Proceeds from exercise of stock warrants | $3.9M | $1.2K |
| Proceeds from induced exercise of stock warrants | $1.0M | |
| Payment of cash issuance costs for induced exercise of stock warrants | -$116.5K | |
| Reverse stock split settlement of fractional shares | -$160 | |
| Repayments of notes payable | -$1.5M | -$5.5M |
| Payment of preferred dividend | -$892.2K | |
| Payment of costs in connection with debt extinguishment | -$136.8K | |
| Net Cash and Cash Equivalents Provided By Financing Activities | $91.0M | $17.6M |
| Net Increase (Decrease) in Cash and Cash Equivalents | $4.3M | -$12.7M |
| Interest | $481.4K | $1.6M |
| Taxes | -$8.1K | $36.1K |
| Deposits of HYPE into liquid staking activities | $58.8M | |
| Redemption of liquid staking tokens for HYPE | $15.9M | |
| Transfer of HYPE to digital asset receivable | $9.9M | |
| Accrued dividend payable | $792.6K | |
| Purchase of insurance policy financed by note payable | $505.1K | |
| Accrual for intangible asset milestone obligation | $2.0M | |
| Reclassification of deferred clinical supply costs to inventories | $3.0M | |
| Modification date carrying value of extinguished Avenue Loan | $10.3M | |
| Modification date fair value of modified Avenue Loan | $10.2M | |
| Warrants issued for debt modification | $858.3K | |
| Warrant modification and additional warrants - incremental value | $1.2M | $2.9M |
| Common stock issued in consideration for equipment received in conjunction with licensing agreement | $135.4K | |
| Conversion of Avenue Loan to common stock | $640.3K | |
| Common stock issued in consideration for licensing agreement | $436.8K | |
| Common stock issued in consideration for reacquisition of licensing agreement | $2.3M | |
| Common stock issued as consideration for modification of loan agreement | $200.0K | |
| Interest expense added to note principal | $367.3K | $102.9K |
| Issuance of common stock related to vested restricted stock units | $53 | |
| Treasury stock held for employee payroll taxes upon the delivery of restricted stock units | $253.6K |
No quarter-by-quarter statement was filed.
Leadership
Who has led HYPERION DEFI, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chief financial officer
Chief operating officer
20202025
- Chief executive officerTsontcho Ianchulev Jan 24, 2018 to Nov 3, 202112
- Chief financial officerDavid R. Knox Oct 1, 2025 to now13
- Chief financial officerAndrew D. Jones Sep 3, 2024 to Sep 3, 202414
- Chief operating officerBren Kern Jan 4, 2023 to now15
Board members and other officers (19)
- Chief Investment OfficerHyunsu Jung Jul 9, 2025 to now16
- VP, Clinical OperationsJennifer G. Clasby Jan 24, 2018 to Jul 21, 202117
- VP, Research and DevelopmentLuke Clauson Apr 12, 2018 to Jun 17, 202118
- Board memberHyunsu Jung Jul 9, 2025 to now16
- Board memberHappy David Walters Sep 9, 2025 to now19
- Board memberMichael S. Geltzeiler Nov 16, 2023 to now20
- Board memberRachel Jacobson Mar 10, 2022 to now21
- Board memberStephen Keith Benjamin Mar 11, 2022 to Jun 29, 202222
- Board memberEllen R. Strahlman Jul 12, 2022 to now23
- Board memberRam Palanki Jul 12, 2022 to now24
- Board memberJulia Haller Apr 1, 2021 to Jun 21, 202225
- Board memberCurt H. Labelle Jan 24, 2018 to Nov 22, 202126
- Board memberErnest Mario Jan 24, 2018 to Nov 22, 202127
- Board memberShuhei Yoshida Jan 24, 2018 to May 16, 201928
- Board memberTsontcho Ianchulev Jan 24, 2018 to now12
- Board memberFredric N. Eshelman Jan 25, 2018 to Nov 22, 202129
- Board memberCharles E. Mather Iv. Apr 5, 2018 to now30
- Board memberKenneth B. Lee Jr. Apr 5, 2018 to Jun 21, 202231
- General counselRobert Rubenstein Jan 12, 2026 to now32
Named in SEC Form D filings
People the company listed in its private-offering notices.
- Executive Officer, DirectorMichael Rowe named Jul 22, 202533
Former names
- EYENOVIA, INC.Aug 24, 2016 to Jun 27, 20252
Timeline
- Jan 24, 2018New chief executive Tsontcho Ianchulev becomes CEO12
Filings
364 filings to the SEC since October 2021: 8 annual reports, 15 quarterly reports, 101 major events, 136 insider forms, 23 large holders, 1 private raises, 80 other. The latest 20:
- Oct 5, 2026SCHEDULE 13G/A EDGAR
- Oct 2, 20268-K EDGAR
- Sep 30, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 18, 20264 OWNERSHIP DOCUMENT EDGAR
- Aug 13, 202610-Q EDGAR
- Aug 12, 20268-K EDGAR
- Jul 8, 20268-K EDGAR
- Jul 1, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 1, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 1, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 1, 20264 OWNERSHIP DOCUMENT EDGAR
- Jul 1, 20268-K EDGAR
- Jul 1, 2026SCHEDULE 13G/A EDGAR
- Jun 5, 20268-K EDGAR
- Jun 2, 20264 OWNERSHIP DOCUMENT EDGAR
- May 28, 20264 OWNERSHIP DOCUMENT EDGAR
- May 15, 202610-Q EDGAR
- May 14, 20268-K EDGAR
- May 6, 20268-K EDGAR
- May 6, 2026424B5 EDGAR
The 364 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
60 open-market trades by officers, directors and large owners since October 2021: 55 buys and 5 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Jung HyunsuSee Remarks | Buy | 1,000 | $3.66 | $3.7K | Form 4 |
| Jun 1, 2026 | Jung HyunsuSee Remarks | Buy | 7,000 | $3.70 | $25.9K | Form 4 |
| Dec 31, 2025 | Knox David R.Chief Financial Officer | Buy | 27,950 | $3.59 | $100.3K | Form 4 |
| Dec 29, 2025 | Strahlman Ellen RDirector | Buy | 23,968 | $3.60 | $86.4K | Form 4 |
| Dec 26, 2025 | Strahlman Ellen RDirector | Buy | 6,912 | $3.86 | $26.7K | Form 4 |
| Dec 18, 2025 | Strahlman Ellen RDirector | Buy | 38,444 | $3.14 | $120.7K | Form 4 |
| Dec 17, 2025 | Walters Happy DavidDirector | Buy | 61,930 | $3.02 | $187.0K | Form 4 |
| Dec 17, 2025 | GELTZEILER MICHAEL SDirector | Buy | 30,000 | $3.01 | $90.3K | Form 4 |
| Aug 28, 2024 | Rowe Michael MChief Executive Officer | Buy | 27,071 | $0.52 | $14.1K | Form 4 |
| Aug 26, 2024 | Rowe Michael MChief Executive Officer | Buy | 50,000 | $0.57 | $28.5K | Form 4 |
| Jul 2, 2024 | Grant Stuart M.10% owner | Buy | 1,515,151 | $0.66 | $1.0M | Form 4 |
| Mar 28, 2024 | Grant Stuart M.10% owner | Buy | 100,000 | $0.98 | $98.0K | Form 4 |
| Mar 19, 2024 | Grant Stuart M.10% owner | Buy | 50,000 | $1.23 | $61.5K | Form 4 |
| Mar 8, 2024 | Grant Stuart M.10% owner | Buy | 10,717 | $1.58 | $16.9K | Form 4 |
| Dec 4, 2023 | Rowe Michael MChief Executive Officer | Buy | 4,890 | $1.36 | $6.7K | Form 4 |
| Sep 29, 2023 | Strahlman Ellen RDirector | Buy | 4,820 | $1.68 | $8.1K | Form 4 |
| Sep 19, 2023 | Rowe Michael MChief Executive Officer | Buy | 1,400 | $1.66 | $2.3K | Form 4 |
| Sep 15, 2023 | Rowe Michael MChief Executive Officer | Buy | 1,137 | $1.75 | $2.0K | Form 4 |
| Aug 17, 2023 | Grant Stuart M.10% owner | Buy | 30,000 | $1.87 | $56.1K | Form 4 |
| Aug 16, 2023 | Grant Stuart M.10% owner | Buy | 45,000 | $1.91 | $86.0K | Form 4 |
All 60 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Avanza Pension ForsakringsaktiebolagetSCHEDULE 13G/A, 7 filings Oct 22, 2025 to Oct 5, 202634
- Avenue Venture Opportunities Fund, L.P.SCHEDULE 13D/A, 7 filings May 15, 2025 to Sep 19, 202535
- Hyunsu JungSCHEDULE 13D, 1 filing Jul 16, 202536
- Stuart M. GrantSC 13D/A, 3 filings Dec 27, 2021 to Dec 4, 202437
- ARMISTICE CAPITAL, LLCSC 13G/A, 2 filings Feb 14, 2024 to Nov 14, 202438
- Tsontcho IanchulevSC 13D/A, 2 filings Jan 24, 2023 to Jul 18, 202439
- Fredric N. EshelmanSC 13D/A, 1 filing Feb 13, 202340
Money raised
Private offerings the company reported to the SEC on Form D.
- Jun 20, 2025Raised $50 million in a private offering of equity Form D: 5 investors so far Form D
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 33. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Vanguard Capital Management LLC | 466,798 | $1.5M | 0.0% | +382,389 |
| Franklin Resources Inc | 395,939 | $1.2M | 0.0% | New |
| Arrington Capital Management, LLC | 297,777 | $935.0K | 1.0% | New |
| Morgan Stanley | 237,986 | $747.3K | 0.0% | No change |
| Almanack Investment Partners, LLC. | 169,013 | $530.7K | 0.1% | New |
| Geode Capital Management, LLC | 130,707 | $410.5K | 0.0% | +53,627 |
| Jane Street Group, LLC | 127,491 | $400.3K | 0.0% | −789 |
| Oppenheimer & Co Inc | 126,365 | $396.8K | 0.0% | +62,097 |
| BlackRock, Inc. | 114,400 | $359.2K | 0.0% | +33,292 |
| Goldman Sachs Group Inc | 91,390 | $287.0K | 0.0% | New |
| Vanguard Fiduciary Trust Co | 74,455 | $233.8K | 0.0% | +46,307 |
| Citadel Advisors LLC | 56,299 | $176.8K | 0.0% | −56,607 |
| State Street Corp | 54,357 | $170.7K | 0.0% | +28,500 |
| UBS Group AG | 33,179 | $104.2K | 0.0% | −15,611 |
| Northern Trust Corp | 30,896 | $97.0K | 0.0% | +12,165 |
| Peak6 LLC | 20,000 | $62.8K | 0.0% | New |
| Investment House LLC | 17,300 | $54.3K | 0.0% | −34,575 |
| Jpmorgan Chase & Co | 16,107 | $51.2K | 0.0% | +16,099 |
| XTX Topco Ltd | 12,289 | $38.6K | 0.0% | −13,286 |
| Nations Financial Group Inc, /ia/ /adv | 11,125 | $34.9K | 0.0% | No change |
| Sanctuary Advisors, LLC | 10,800 | $33.9K | 0.0% | No change |
| Barclays PLC | 1,807 | $5.7K | 0.0% | New |
| Jones Financial Companies Lllp | 1,768 | $5.4K | 0.0% | New |
| Wells Fargo & Company/mn | 1,230 | $3.9K | 0.0% | +1,200 |
| SBI Securities Co., Ltd. | 1,219 | $3.8K | 0.0% | −695 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15SEC EDGARBren Kern, Chief operating officer
- 16
- 17
- 18
- 19SEC EDGARHappy David Walters, Board member
- 20SEC EDGARMichael S. Geltzeiler, Board member
- 21SEC EDGARRachel Jacobson, Board member
- 22SEC EDGARStephen Keith Benjamin, Board member
- 23SEC EDGAREllen R. Strahlman, Board member
- 24SEC EDGARRam Palanki, Board member
- 25SEC EDGARJulia Haller, Board member
- 26SEC EDGARCurt H. Labelle, Board member
- 27SEC EDGARErnest Mario, Board member
- 28SEC EDGARShuhei Yoshida, Board member
- 29SEC EDGARFredric N. Eshelman, Board member
- 30SEC EDGARCharles E. Mather Iv., Board member
- 31SEC EDGARKenneth B. Lee Jr., Board member
- 32SEC EDGARRobert Rubenstein, General counsel
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40